|

Savolitinib, Crizotinib. Clinical Trials

1 actively recruiting trial

Also known as: Crizotinib

Pipeline

Phase 2: 1

Top Sponsors

  • Hunan Province Tumor Hospital1

Indications

  • MET Gene Mutation1
  • ROS1 Gene Mutation1
  • ALK Gene Mutation1
  • Lung Cancer1
  • EGFR Gene Mutation1

Other1 trial

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.